AMTX
Aemetis, Inc. NASDAQ Listed Jun 27, 2006$3.12
Mkt Cap $212.6M
52w Low $1.22
73.6% of range
52w High $3.80
50d MA $2.51
200d MA $2.19
P/E (TTM)
-2.8x
EV/EBITDA
-14.6x
P/B
—
Debt/Equity
-1.0x
ROE
25.1%
P/FCF
-4.0x
RSI (14)
—
ATR (14)
—
Beta
1.48
50d MA
$2.51
200d MA
$2.19
Avg Volume
1.5M
Aemetis, Inc. operates as a renewable natural gas and renewable fuels company in North America and India. It operates through three segments: California Ethanol, Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the acquisition, development, and commercialization of negative carbon intensity products and technologies that replace traditional petroleum-based products. It sells biodiesel primarily to government oil marketing companies, transport companies, resellers, distributors, and private refiners through its own sales force and independent sales agents, as well as to brokers who resell the product to end-users. The company also produces and sells ethanol; and wet distillers grains, distillers corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. In addition, it produces dairy biogas; produces and sells high-grade alcohol and various feed products, as well as hand sanitizers; and researches and develops conversion technologies using waste feedstocks to produce biofuels and biochemicals. The company was formerly known as AE Biofuels, Inc. and changed its name to Aemetis, Inc. in November 2011. Aemetis, Inc. was founded in 2005 and is headquartered in Cupertino, California.
20400 Stevens Creek Boulevard · Cupertino, CA 95014 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | BMO | — | — | — | 3.24 | -4.9% | -3.7% | — | — | — | — | — |
| Mar 12, 2026 | AMC | -0.27 | -0.24 | +11.1% | 1.92 | +0.0% | +19.3% | -3.9% | +24.1% | +0.4% | -3.6% | — |
| Nov 6, 2025 | AMC | -0.25 | -0.37 | -48.0% | 1.76 | -0.6% | +19.3% | +0.5% | +2.4% | -4.6% | -5.3% | — |
| Aug 7, 2025 | AMC | -0.35 | -0.41 | -17.1% | 2.42 | +2.5% | +10.3% | -1.1% | +4.9% | -0.7% | -3.6% | — |
| May 8, 2025 | AMC | -0.39 | -0.47 | -20.5% | 1.36 | +0.0% | -5.1% | +10.1% | +6.3% | +2.6% | +5.2% | — |
| Mar 13, 2025 | AMC | -0.46 | -0.36 | +21.7% | 1.59 | +0.0% | +5.7% | +21.4% | -3.4% | +1.5% | -0.5% | — |
| Nov 12, 2024 | AMC | -0.47 | -0.38 | +19.1% | 4.62 | -1.1% | -10.6% | -1.5% | -5.9% | -1.3% | +4.0% | — |
| Aug 1, 2024 | AMC | -0.58 | -0.66 | -13.8% | 2.66 | +3.4% | -6.4% | +1.6% | +4.3% | -4.5% | +2.0% | — |
| May 9, 2024 | AMC | -0.43 | -0.58 | -34.9% | 4.11 | -0.2% | -2.7% | +0.2% | +1.7% | +1.7% | -5.8% | — |
| Mar 7, 2024 | AMC | -0.35 | -0.64 | -82.9% | 3.26 | +2.1% | +3.1% | -4.5% | +0.3% | +2.5% | -3.0% | — |
| Nov 9, 2023 | AMC | -0.23 | -0.59 | -156.5% | 4.61 | -0.2% | -2.0% | -2.9% | +4.6% | +6.8% | -0.8% | — |
| Aug 3, 2023 | AMC | -0.28 | -0.68 | -142.9% | 7.53 | -0.3% | -0.9% | -7.9% | +3.8% | -2.0% | -2.0% | — |
| May 4, 2023 | AMC | -0.29 | -0.73 | -151.7% | 1.75 | -3.4% | +6.9% | +21.4% | -15.0% | -10.4% | +2.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 8 | Ascendiant Capital | Maintains | Buy → Buy | — | $2.93 | $2.92 | -0.3% | -5.5% | -13.4% | -5.4% | +8.4% | -7.3% |
| Nov 19 | Ascendiant Capital | Maintains | Buy → Buy | — | $1.76 | $1.75 | -0.6% | -4.5% | -8.3% | +3.9% | +3.1% | +0.0% |
| Oct 6 | Ascendiant Capital | Maintains | Buy → Buy | — | $2.65 | $2.72 | +2.6% | +10.9% | +2.0% | -5.7% | +1.1% | -8.0% |
| Jun 30 | UBS | Maintains | Buy → Buy | — | $2.35 | $2.50 | +6.4% | +5.5% | +0.8% | +4.8% | +16.8% | +8.2% |
| Jun 6 | Ascendiant Capital | Maintains | Buy → Buy | — | $1.72 | $1.79 | +4.1% | +13.4% | +2.1% | +1.0% | -4.5% | -0.5% |
| May 9 | UBS | Maintains | Buy → Buy | — | $1.36 | $1.36 | +0.0% | -5.1% | +10.1% | +6.3% | +2.6% | +5.2% |
| Mar 17 | Ascendiant Capital | Maintains | Buy → Buy | — | $1.68 | $1.72 | +2.4% | +21.4% | -3.4% | +1.5% | -0.5% | +1.0% |
| Mar 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.59 | $1.59 | +0.0% | +5.7% | +21.4% | -3.4% | +1.5% | -0.5% |
| Dec 23 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.62 | $2.65 | +1.1% | -1.1% | +1.5% | +8.7% | -1.7% | +0.0% |
| Nov 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.07 | $4.10 | +0.7% | -5.9% | -1.3% | +4.0% | -1.5% | +5.7% |
| Sep 3 | Ascendiant Capital | Maintains | Buy → Buy | — | $2.46 | $2.42 | -1.6% | -7.3% | -0.9% | -1.8% | -0.5% | +2.7% |
| Aug 19 | UBS | Maintains | Buy → Buy | — | $2.81 | $2.85 | +1.4% | +0.0% | -7.5% | -0.8% | -3.5% | +6.0% |
| Aug 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.66 | $2.75 | +3.4% | -6.4% | +1.6% | +4.3% | -4.5% | +2.0% |
| Jul 31 | Truist | Maintains | Hold → Hold | — | $3.42 | $3.45 | +0.9% | -6.1% | -17.1% | -6.4% | +1.6% | +4.3% |
| May 13 | Truist | Maintains | Hold → Hold | — | $4.00 | $3.96 | -1.0% | +0.2% | +1.7% | +1.7% | -5.8% | -1.5% |
| May 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.11 | $4.10 | -0.2% | -2.7% | +0.2% | +1.7% | +1.7% | -5.8% |
| Mar 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.26 | $3.33 | +2.1% | +3.1% | -4.5% | +0.3% | +2.5% | -3.0% |
| Feb 21 | Stifel | Maintains | Buy → Buy | — | $3.86 | $3.83 | -0.8% | -5.2% | -4.1% | +4.3% | -0.3% | -3.0% |
| Jan 23 | Truist | Maintains | Hold → Hold | — | $3.30 | $3.37 | +2.1% | +6.4% | -5.1% | +3.9% | +0.3% | +7.2% |
| Jan 23 | Stifel | Maintains | Buy → Buy | — | $3.30 | $3.37 | +2.1% | +6.4% | -5.1% | +3.9% | +0.3% | +7.2% |
| Nov 27 | Stifel | Maintains | Buy → Buy | — | $4.81 | $4.80 | -0.2% | -2.9% | -3.6% | -2.9% | +1.6% | +5.9% |
| Sep 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.16 | $5.22 | +1.2% | -2.3% | -5.8% | +4.2% | -3.6% | -10.3% |
| Aug 22 | Stifel | Maintains | Buy → Buy | — | $5.20 | $5.29 | +1.7% | -0.4% | +0.2% | -7.9% | +4.2% | -0.8% |
| Aug 16 | UBS | Upgrade | Neutral → Buy | — | $6.16 | $6.54 | +6.2% | -5.8% | -2.2% | -7.6% | -0.8% | -0.4% |
| Aug 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.53 | $7.51 | -0.3% | -0.9% | -7.9% | +3.8% | -2.0% | -2.0% |
| Jul 7 | Stifel | Maintains | Buy → Buy | — | $6.99 | $7.29 | +4.3% | +8.4% | +4.4% | +1.8% | +8.1% | -6.3% |
| Jun 6 | Piper Sandler | Maintains | Underweight → Underweight | — | $5.76 | $5.70 | -1.0% | +20.7% | -17.8% | +5.4% | +10.1% | +15.8% |
| Apr 27 | Stifel | Maintains | Buy → Buy | — | $2.02 | $2.03 | +0.5% | +6.9% | +2.8% | -6.8% | +0.0% | +4.8% |
| Apr 14 | Stifel | Maintains | Buy → Buy | — | $2.16 | $2.13 | -1.4% | +3.2% | +6.7% | -2.1% | -3.0% | -8.4% |
| Apr 13 | Truist | Maintains | Hold → Hold | — | $2.20 | $2.19 | -0.5% | -1.8% | +3.2% | +6.7% | -2.1% | -3.0% |
| Feb 1 | Truist | Maintains | Hold → Hold | — | $4.67 | $4.56 | -2.4% | -1.5% | +2.2% | -0.2% | -3.6% | -3.3% |
| Aug 9 | Truist | Downgrade | Buy → Hold | — | $11.12 | $10.41 | -6.4% | -8.5% | +3.2% | +1.5% | +1.8% | -3.6% |
| Jun 13 | Credit Suisse | Maintains | Outperform → Outperform | — | $7.31 | $6.89 | -5.7% | -13.7% | -6.5% | -0.5% | -8.0% | +1.3% |
| Aug 23 | Credit Suisse | Maintains | Outperform → Outperform | — | $8.54 | $8.55 | +0.1% | +1.9% | +13.7% | +4.4% | -1.5% | +5.0% |
No insider trades available.
8-K · 2.02
!! High
Aemetis, Inc. -- 8-K 2.02: Earnings Results
Aemetis reported earnings results via 8-K filing, though specific financial metrics require reviewing the attached press release to assess operational performance and investor implications.
May 7
8-K · 4.01
!!! Very High
Unknown — 8-K 4.01: Auditor Change / Resignation
AMTX's auditor switch to RSM with disagreements on financial statements raises red flags about accounting practices, potentially signaling asset valuation or disclosure issues that warrant investor scrutiny.
Mar 16
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
AMTX's $208 million 2025 revenue demonstrates stable operations in renewable fuels, but investors should monitor whether production tax credits remain sustainable and if margins expand as the company scales.
Mar 12
8-K · 8.01
!! High
Aemetis, Inc. (DE) -- 8-K 8.01: Material Event / Announcement
Aemetis updated its capital stock description in SEC filings, which will supersede prior versions and become available for incorporation into future registration statements.
Feb 19
8-K · 1.01
! Medium
Aemetis, Inc. (DE) -- 8-K 1.01: Financing / Debt Agreement
Aemetis secured a $114.7 million financing agreement with Protair-X Technologies, providing capital to support its sustainable fuel and biotech operations.
Feb 6
Data updated apr 24, 2026 6:01pm
· Source: massive.com